05:16 PM EDT, 03/27/2025 (MT Newswires) -- Elutia ( ELUT ) said Thursday it entered an agreement to offer EluPro to Advantus Health Partners' group purchasing organizations solutions portfolio .

EluPro is an antibiotic-eluting bio envelope designed for use with neurostimulators and cardiac implantable electronic devices. The biomatrix regenerates into the patient's tissue to minimize post-operative challenges, the company said.